+1 / +2

https://www.sec.gov/ix?doc=/Archives/edgar/data/1038469/000174177323000161/c497.htm
T. Rowe Price QM Global Equity Fund
Supplement to Prospectus and Summary Prospectus dated May 1, 2022
Effective April 5, 2023, the fund’s name will change from the T. Rowe Price QM Global Equity Fund to the T. Rowe Price Integrated Global Equity Fund. All references throughout the prospectus and summary prospectus to the QM Global Equity Fund are replaced by reference to the Integrated Global Equity Fund.
In connection with this change, effective April 5, 2023, the third and fourth paragraphs under “Principal Investment Strategies” beginning on page 2 will be replaced with the following:
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
In addition, effective April 5, 2023, the fourth, fifth, and sixth paragraphs under “Principal Investment Strategies”, which begins on page 9 of the prospectus, will be replaced with the following:
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. The fund draws on the adviser’s experience in global equity investing and takes into account both its quantitative and fundamental research capabilities. The portfolio is typically constructed in a “bottom up” manner, an approach that focuses more on evaluations of individual stocks than on analyses of overall economic trends and market cycles. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
The date of this supplement is February 3, 2023.
F203-041 2/3/23

https://www.sec.gov/ix?doc=/Archives/edgar/data/1038469/000174177323000160/c497.htm
T. Rowe Price QM U.S. Small & Mid-Cap Core Equity Fund
Supplement to Prospectus and Summary Prospectus dated May 1, 2022
Effective April 5, 2023, the fund’s name will change from the T. Rowe Price QM U.S. Small & Mid-Cap Core Equity Fund to the T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund. All references throughout the prospectus and summary prospectus to the QM U.S. Small & Mid-Cap Core Equity Fund are replaced by reference to the Integrated U.S. Small-Mid Cap Core Equity Fund.
In connection with this change, effective April 5, 2023, the third and fourth paragraphs under “Principal Investment Strategies” beginning on page 2 will be replaced with the following:
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
In addition, effective April 5, 2023, the third and fourth paragraphs under “Principal Investment Strategies” on page 9 of the prospectus will be replaced with the following:
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. The fund draws on the adviser’s experience in small- and mid-cap investing and takes into account both its quantitative and fundamental research capabilities. The portfolio is typically constructed in a “bottom up” manner, an approach that focuses more on evaluations of individual stocks than on analyses of overall economic trends and market cycles. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
The date of this supplement is February 3, 2023.
F202-041 2/3/23

https://www.sec.gov/ix?doc=/Archives/edgar/data/1038469/000174177323000159/c497.htm
T. Rowe Price QM U.S. Value Equity Fund
Supplement to Prospectus and Summary Prospectus dated May 1, 2022
Effective April 5, 2023, the fund’s name will change from the T. Rowe Price QM U.S. Value Equity Fund to the T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund. All references throughout the prospectus and summary prospectus to the QM U.S. Value Equity Fund are replaced by reference to the Integrated U.S. Large-Cap Value Equity Fund.
In connection with this change, effective April 5, 2023, the first three paragraphs under “Principal Investment Strategies” beginning on page 2 will be replaced with the following:
Under normal conditions, the fund invests at least 80% of its net assets (including any borrowings for investment purposes) in equity securities issued by large-cap U.S. companies. The fund expects to invest predominantly in the common stocks of companies that appear to be undervalued by various measures.
The fund defines a large-cap company as one whose market capitalization falls within the market capitalization range of the Russell 1000® Index. As of December 31, 2022, the market capitalization range for the Russell 1000® Index was approximately $0.65 to $2,066.94 billon.
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
In addition, effective April 5, 2023, the first three paragraphs under “Principal Investment Strategies” beginning on page 10 of the prospectus will be replaced with the following:
Under normal conditions, the fund invests at least 80% of its net assets (including any borrowings for investment purposes) in equity securities issued by large-cap U.S. companies. The fund expects to invest predominantly in the common stocks of companies that appear to be undervalued by various measures. Shareholders will receive at least 60 days’ prior notice of a change in the policy. The fund expects to invest predominantly in the common stocks of companies that appear to be undervalued by various measures.
The fund defines a large-cap company as one whose market capitalization falls within the market capitalization range of the Russell 1000® Index. As of December 31, 2022, the market capitalization range for the Russell 1000® Index was approximately $0.65 to $2,066.94 billion. The market capitalization of the companies in the fund’s portfolio and the Russell index changes over time; the fund will not automatically sell or cease to purchase stock of a company it already owns just because the company’s market capitalization falls below the market capitalization range of companies in the Russell index.
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. The fund draws on the adviser’s experience in large-cap investing and takes into account
both its quantitative and fundamental research capabilities. The portfolio is typically constructed in a “bottom up” manner, an approach that focuses more on evaluations of individual stocks than on analyses of overall economic trends and market cycles. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
As part of the stock selection process, the adviser focuses primarily on companies whose securities, in the adviser’s opinion, are undervalued. The adviser employs various valuation metrics, such as price-to-earnings, price-to-cash flows, and price-to-book ratios, and compares these ratios with others in the relevant investing universe.
The date of this supplement is February 3, 2023.
F201-041 2/3/23

https://www.sec.gov/ix?doc=/Archives/edgar/data/1038469/000174177323000158/c497.htm
T. Rowe Price QM U.S. Small-Cap Growth Equity Fund
Supplement to Prospectus and Summary Prospectus dated May 1, 2022
Effective April 5, 2023, the fund’s name will change from the T. Rowe Price QM U.S. Small-Cap Growth Equity Fund to the T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund. All references throughout the prospectus and summary prospectus to the QM U.S. Small-Cap Growth Equity Fund are replaced by reference to the Integrated U.S. Small-Cap Growth Equity Fund.
In connection with this change, effective April 5, 2023, the third and fourth paragraphs under “Principal Investment Strategies” on page 2 will be replaced with the following:
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
As part of the stock selection process, the adviser focuses primarily on companies that, in the adviser’s opinion, are capable of achieving and sustaining above-average, long-term earnings growth.
At times, the fund may have a significant portion of its assets invested in the same economic sector.
In addition, effective April 5, 2023, the third and fourth paragraphs under “Principal Investment Strategies” on page 10 of the prospectus will be replaced with the following:
The fund’s integrated approach to investing combines fundamental analysis and quantitative models to identify stocks that could be included in the portfolio. The fund draws on the adviser’s experience in small-cap investing and takes into account both its quantitative and fundamental research capabilities. The portfolio is typically constructed in a “bottom up” manner, an approach that focuses more on evaluations of individual stocks than on analyses of overall economic trends and market cycles. Stocks are selected based on a variety of metrics such as a company’s valuation, profitability, stability, earnings quality, management capital allocation actions, and indicators of near-term appreciation potential.
As part of the stock selection process, the adviser focuses primarily on companies that, in the adviser’s opinion, are capable of achieving and sustaining above-average, long-term earnings growth. The adviser employs various growth metrics, such as a company’s historical and forecasted sales and earnings growth rates.
At times, the fund may have a significant portion of its assets invested in the same economic sector.
The date of this supplement is February 3, 2023.
F120-041 2/3/23

I believe, @Observant1, that I bought the Investor shares of the same fund that you mention.

Yes - same fund but different share class.
As Mona mentioned, SIVLX is available at Vanguard where I have an account.
It has a $25K minimum initial investment.
I believe SFVLX has a $2500 minimum initial investment.

SFVLX can be purchased with a minimum of $2,500 in a regular account and $1,000 in a retirement account directly with Seafarer. I do not see where SFVLX can be purchased through Vanguard or Schwab.

The strategy had $400million+ in assets 10 years ago....now, $33million. It's been a tough time to focus on this part of the world. A tough 10 year run. Economics can't make sense to keep this running.

I hit a paywall with the Barrons article.
As of yesterday, the 7 day SEC yield for VMRXX was 4.31%.
Is that with or without the fee waiver?

You may want to check if your local library system offers Proquest.
I'm able to access Barron's and Wall Street Journal articles online using Proquest.

I believe, @Observant1, that I bought the Investor shares of the same fund that you mention.

Yes - same fund but different share class.
As Mona mentioned, SIVLX is available at Vanguard where I have an account.
It has a $25K minimum initial investment.
I believe SFVLX has a $2500 minimum initial investment.

Year 2000 inception. Down for the full period by -49.47%. For the previous 1-year, to 02 Feb, it's down -80.38%. Share price at inception was typical: $10.00. Share price tonight = $2.96. Rather dismal. I suppose it's been exactly the wrong geographical area to open a new dedicated fund. Think about Hungarian nonsense with Orban. Think about the putrid leadership in Belarus, Russia. Think about the invasion of Ukraine. Moldova might be a bright spot, but there's corruption there, so I've read. But at least the leadership supports Ukraine. The Russian-led insurgency in Transnistria is like a boil on the ass of Progress, not to mention the injustice of it all. (Integrity of national borders, and all that good stuff. But that means nothing to the Poot-doink.)
Montenegro: In 2015, the investigative journalists' network OCCRP named Montenegro's long-time President and Prime Minister Milo Đukanović "Person of the Year in Organized Crime." Dreadful.
The wrong fund at the wrong time. But 23 years ago, things looked different, surely.
For convenience, here's the ticker: TREMX.

A similar check for Fidelity core/settlement m-mkt fund SPAXX with FYs 5/1-4/30,
2018 0.42%
2019 0.42%
2020 0.42%
2021 0.15%
2022 0.10%
Now 0.42%

https://www.sec.gov/Archives/edgar/data/313212/000174177323000146/c497.htm
497 1 c497.htm EEM STAT AND SUM STICKER 2.2.23
T. Rowe Price Emerging Europe Fund
Supplement to Prospectus and Summary Prospectus dated March 1, 2022, as supplemented
Effective Friday, February 17, 2023, the T. Rowe Price Emerging Europe Fund will close to all purchases. Accordingly, the summary prospectus and prospectus are updated as follows:
In the summary prospectus and section 1 of the prospectus, the disclosure under “Purchase and Sale of Fund Shares” is supplemented as follows:
Effective at the close of the New York Stock Exchange on Friday, February 17, 2023, the fund will close to all purchases from new and existing shareholders.
Section 2 of the prospectus is supplemented as follows:
CLOSED TO NEW PURCHASES
Currently, the fund is generally closed to new investors and new accounts, subject to certain exceptions. Effective at the close of the New York Stock Exchange on Friday, February 17, 2023, the fund will close to all purchases from new and existing shareholders. After February 17, 2023, even investors who already hold shares of the fund either directly with T. Rowe Price or through a retirement plan or financial intermediary may no longer purchase additional shares.
Shareholders with existing accounts may reinvest dividends and capital gains so long as they own shares of the fund in their account. In addition, the fund reserves the right, when in the judgment of T. Rowe Price it is not adverse to the fund’s interests, to permit certain types of purchases. The fund’s closure to additional purchases does not restrict existing shareholders from redeeming shares of the fund.
The date of this supplement is February 2, 2023.
F131-043 2/2/23

I checked the prospectus (download) for 5-yr history of operating expenses. For VMFXX, for FYs (9/1-8/31),
2018 0.11%
2019 0.11%
2020 0.11%
2021 0.09%
2022 0.09%
Now 0.11% (see the screen shot from today)
So, the waiver was 2 bps that doesn't seem large but can be substantial on $220+ billions ($40+ million). For VG investors, this isn't a big deal. But it may be a bigger issue for other m-mkt funds that have typical ERs of 0.35-0.50%. Those m-mkt funds were being operated at substantial losses during the ZIRP, and many were shut or merged.
https://i.ibb.co/wSm6hrD/Screenshot-2023-02-02-18-11-45.png

I would say it is with fee waiver. If you subscribe to Apple News ($10/month), you get SOME articles which are behind the paywall including Barron’s, WSJ, and Washington Post.

But now that the Federal Reserve has hiked interest rates repeatedly, taking the federal-funds rate to 4.5% on Wednesday, Vanguard money funds have sufficiently plump yields to absorb the costs and still deliver a meaningful return to investors. For example, the Vanguard Federal Money Market Fund yields 4.3%, and the Municipal Money Market yields 1.6% tax-free.  
Vanguard hasn’t announced it was reducing the fee waivers, which arguably reflect a return to a more normal state of affairs now that rates are no longer near zero. Instead, one can see the shift in the funds’ annual reports. 

AAPL - A tech giant. Favorite target of many short sellers. WB holds a bunch.
STORY (Apple)
Some additional after market news: (Excerpted & edited for brevity)
”Amazon (AMZN) -The online giant's net sales $149.20 billion for the fourth quarter came in above analyst expectations of $145.8 billion. Its adjusted earnings of 3 cents per share came in below estimates of 17 cents. Amazon's AWS cloud unit net sales came in at $21.38 billion, a growth of more than 20% compared to the same period in 2022. Operating income came in at $2.74 billion, beating analyst expectations of $2.51 billion.
“Alphabet (GOOGL, GOOG) - Shares of Google parent Alphabet are trading 6% lower in after hours. The tech giant reported fourth quarter sales, excluding partner payouts, of $63.1 billion versus analyst expectations of $63.2 billion. Advertising revenue fell by 4% while YouTube revenue dropped 8%, reflecting a challenging ad environment amid a slowing economy.
“Apple (AAPL) - Shares fell about 4% in after hours after the tech giant's quarterly revenue of $117.15 billion declined by 5% year-over-year, missing analyst expectations of $121.14. iPhone sales dropped 8% year-over-year to $65.8 billion, missing estimates of $68.3 billion. The company's earnings per share of $1.88 vs also came in below expectations of $2.10.”
Source: Excerpted from Yahoo Finance
In late night trading, NASDAQ futures were down more than 200 points or about -1.6%. S&P futures showing smaller losses. (For context, the NASDAQ gained 384 points on Thursday.)

Vanguard is beginning to remove fee-waivers/ER-caps for m-mkt funds that had been in place during the ZIRP. Investors may notice the changes as most are watching rates very closely. Affected are "...Vanguard Municipal Money Market (ticker: VMSXX), Vanguard Federal Money Market Fund (VMFXX), and Vanguard Cash Reserves Federal Money Market (VMRXX)....Vanguard hasn’t announced it was reducing the fee waivers, which arguably reflect a return to a more normal state of affairs now that rates are no longer near zero....".
Other m-mkt funds are expected to do the same.
By @LewisBraham
https://www.barrons.com/articles/vanguard-money-market-fund-fee-waivers-51675291662?mod=bol-social-tw

I hit a paywall with the Barrons article. As of yesterday, the 7 day SEC yield for VMRXX was 4.31%. Is that with or without the fee waiver?

+1 hank Both XLP and RHS have lost money so far in 2023.

I believe, @Observant1, that I bought the Investor shares of the same fund that you mention.

SP500 with AAII Bull-Bear Ratio (add today's reading 0.86; more common is Bull-Bear Spread) from Twitter LINK.

Yes sirs
After 12 months downtrends